CN Stock MarketDetailed Quotes

Nanjing Hicin Pharmaceutical (300584)

Watchlist
  • 43.83
  • +0.06+0.14%
Market Closed Apr 17 15:00 CST
5.26BMarket Cap117.51P/E (TTM)

Nanjing Hicin Pharmaceutical (300584) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Cardio-cerebrovascular class268.84M87.12%
Antibiotics17.56M5.69%
APIs and intermediates5.2M1.68%
Digestive class4.63M1.50%
Antiviral class4.52M1.47%
Other business2.56M0.83%
Immune regulatory class2.48M0.80%
Other classes1.75M0.57%
Diuretics1.04M0.34%
View all

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry504.36M100.00%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China region122.06M39.55%
North China81.18M26.31%
South China32.93M10.67%
Central China28.87M9.36%
Northwest region16.19M5.25%
Southwest area14.61M4.74%
Northeast area10.17M3.30%
Other business2.56M0.83%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More